Aspirin merits testing for prevention of cervical cancer in HIV-
infected women
Research conducted by NewYork-Presbyterian Hospital/Weill Cornell
Medical Center global health investigators and cancer specialists in
New York, Qatar and Haiti suggests that aspirin should be evaluated
for its ability to prevent development of cervical cancer in HIV-
infected women.
In Medical Xpresshttp://medicalxpress.com/news/2012-01-aspirin-merits-cervical-cancer-hiv-infected.html

Scriptaid Revives Breast Cancer Treatment Receptivity
A study by researchers from the Sbarro Institute for Cancer Research
and Molecular Medicine, reveals that despite the effectiveness of
endocrine therapy for breast cancer, responsiveness to the treatment
depends on expression of estrogen receptors in breast cancer cells.
However, Dr. Laura Giacinti, lead investigator of the study reports on
a new molecule, Scriptaid, which revives receptivity to the treatment
in breast cancer cell lines that previously tested negative for the
expression of estrogen receptors. The study appears in the Journal of
Cellular Physiology..
By Grace Rattue. In Medical News Todayhttp://www.medicalnewstoday.com/articles/240479.php

Metastasis of pancreatic cancer in action
Ben Stanger, MD, PhD, assistant professor of Medicine in the Division
of Gastroenterology at the Perelman School of Medicine, University of
Pennsylvania, and Andrew Rhim, MD, a Gastroenterology Fellow in the
Stanger lab, discovered that pancreatic cancer cells in an animal
model begin to spread before clinically obvious tumor tissue is
detected. What's more, they showed that inflammation enhances cancer
progression in part by facilitating a cellular transformation that
leads to entry of cancer cells into the circulation. They report their
findings this week in Cell.
In EurekAlert.http://www.eurekalert.org/pub_releases/2012-01/uops-mop011312.php